This study aimed to explore the mechanism of TGQZD on improvement of inflammatory damage and dyslipidemia caused by NAFLD through the CGI-58/ROS/NLRP3 inflammasome pathway. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatotic liver disease.